Dataset ID: 11

Back to List

Dataset Details

Study Design
Study Design Background
To synthesis and evaluation of a PSMA-617-targeted dual NIRF PDTprobe conceived using IRDye700DX as photosensitizer and FGS NIR dye.
Study Description
Probe conceived using IRDye700DX as photosensitizer and FGS NIR dye
Study Type
Preclinical
Study Subtype
In vivo ex vivo
Publication
Paper Linked
Yes
Paper Title
A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation
Paper Authors
Capozza, Martina; Stefania, Rachele; Dinatale, Valentina; Bitonto, Valeria; Conti, Laura; Grange, Cristina; Skovronova, Renata; Terreno, Enzo
Affiliation
Molecular & Preclinical Imaging Centers, Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy ; Molecular Biotechnology Center, Department of Medical Science, University of Torino, 10126 Torino, Italy; Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy
Paper Journal
IJMS
Paper Year
2022
Paper DOI
Open Access
Yes
Study Component
Multi Modality Images
Yes
Imaging Modality
MRI, OI
Imaging Sub Modality
T2w and fluorescent imaging (filter pair: 640 720 nm)
Radiation
No
Imaging Coverage
Body
Imaging Target
PSMA
Dataset Information
Institution
UniTO
PI
Enzo Terreno
Country Of Institution
Italy
Imaging Facility
Laboratory of molecular imaging for small animal
Euro Bio Imaging Node
MMMI
Country Of Imaging Facility
Italy
Contact Person
In Vivo Experimental Parameters
Number Of Groups
5
Types Of Groups
1nmol PSMA+ inj biod; 5nmol PSMA+ inj biod; 5 nmol PSMA- biod; PSMA+ PDT treated; PSMA+ Ctrl
Overall Sample Size
25
Disease Model
Cancer
Organ Or Tissue
Prostate
Sample Size For Each Group
5, 5, 5, 5, 5
Randomization
Mice were randomly divided into treted and control group
Blinding
No
Outcome Measures
Fluorescent uptake, tumor volume
Statistical Methods
Anova and t-test
Species
Strain
Athymic nude
Immune Status
Immunodeficient
Sex
Male
Age
5 weeks
Age At Start Experiment
6 weeks
Age At Scanning Experiment S
Older than 8 weeks
Weight
20g
Weight At Start Experiment
20
Weight At End Experiment
20
Source Of Animals
Envigo
Registry Number Of Animal Authorization
229 2016
Experimental Procedures
Pharmacological Drug
IRDye700DX-PSMA
Company
Unito
Formulation
PBS
Drug Dose
1-5 nmol mice
Site Or Route Of Administration
Iv
Frequency Of Administration
Once
Vehicle Or Carrier Solution Formulation
PBS
Blood Sampling
No
Pathogen Infection Intervention And Control
No
Analgesic Plan To Relieve Pain Suffering And Distress
No
Anesthesia Type
Intramuscolar
Duration
45
Anesthesia Drugs
Zoletil Rompun
Anesthesia Dose
20 mg kg tiletamine zolazepam (Zoletil 100; Virbac, Milan, Italy) and 5 mg kg xylazine (Rompun; Bayer, Milan, Italy).
Euthanasia
Yes
Method
Cervival dislocation
Histology
Yes
Tissues Collected Post Euthanasia
Tumor
Timing Of Collection
Different time points
Histological Procedure
Optical cutting temperature (OCT) compound
Name Of Reagent S
Anti-CD68, anti PSMA, anti CD31,
Frequency Of Imaging
2 times week MRI
Timing Of Imaging
Three weeks after inoculation
Overall Scan Length
20 min
Contrast Agent Or Radio Isotope Or Challenge With Gas Molecule
No
Cell Line
PC3-PIP and PC3-FLU
Provenance
THE JOHNS HOPKINS UNIVERSITY
Modified Cell Line
Yes
Type Of Genetic Modification
Plasmid
Gene Modified
PSMA
Cell Injection Route
Subcutaneous
Number Of Cells
2x10^6
Housing Room
SPF and not SPF
Dietary Intervention
Diet for OI
Image Acquisition
Instrument Vendor
Bruker for MRI and Perkin Elmer for OI
Instrument Type
7 T Bruker Pharmascan, IVIS spectrum
Instrument Specifics
7T
Raw Data
Yes
QA/QC
No
Image Data
Image Scale
Average radiance efficiency for OI
Format Compression
Raw
Dimensions
2D
Overall Number Of Images
32 x MRI; 7 x OI
Field Of View
30x30 for MRI; D for Ivis
Dimension Extents
128x128
Size Description
30x30x2 mm
Image Processing Methods
Default
Analyzed Data
Analysis Result Type
Numerical
Data Used For Analysis
ROI
Analysis Method And Details
Manual
File Format Of Result File Csv Json Txt Xlsx
Xlsx
Status
Complete
Updated Year
2023